Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Thuja orientalis and Thuja occidentalis essential oils have medicinal properties useful for developing treatments with antimicrobial and bioactive effects.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Tridax procumbens is a widely used medicinal plant with many health benefits.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Genomic research can help improve the quality and production of natural fibers in animals.

Caspase-1 helps hair stem cells move to heal wounded or inflamed skin.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Enzymes can release hydrocarbons from Botryococcus braunii without harming cells, suggesting potential for continuous extraction.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Lipid-based nanocosmeceuticals improve skin therapy by enhancing ingredient delivery and effectiveness for anti-aging and skin disorders.

Pantethine may boost the immune system's ability to fight sarcoma.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.